Activation of the IL-6R/Jak/stat pathway is associated with a poor outcome in resected pancreatic ductal adenocarcinoma. (Q54447837)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23435739%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Activation of the IL-6R/Jak/stat pathway is associated with a poor outcome in resected pancreatic ductal adenocarcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23435739%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23435739%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Joanne Edwards

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23435739%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Karin Oien

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23435739%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Simon M Denley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23435739%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Nigel B Jamieson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23435739%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Pamela McCall

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23435739%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

C Ross Carter

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23435739%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Colin J McKay

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23435739%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

23 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23435739%20AND%20SRC:MED&resulttype=core&format=json

Journal of Gastrointestinal Surgery

24 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23435739%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23435739%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23435739%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

887-898

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23435739%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

cites work

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

A prospective comparison of the prognostic value of tumor- and patient-related factors in patients undergoing potentially curative surgery for pancreatic ductal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Predictors of pancreatic cancer mortality among a large cohort of United States adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

STATs in cancer inflammation and immunity: a leading role for STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

STAT3 expression, molecular features, inflammation patterns, and prognosis in a database of 724 colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Inflammation and cancer: IL-6 and STAT3 complete the link.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Dual roles for immunity in gastrointestinal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Persistent expression of PDX-1 in the pancreas causes acinar-to-ductal metaplasia through Stat3 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

The relationship between tumor inflammatory cell infiltrate and outcome in patients with pancreatic ductal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Activation of the PIK3CA/AKT pathway suppresses senescence induced by an activated RAS oncogene to promote tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Observer variation in immunohistochemical analysis of protein expression, time for a change?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits Pparγ expression and promotes pancreatic cancer progression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Differential regulation of interleukin-6 receptor and gp130 gene expression in rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Transcriptional responses to polypeptide ligands: the JAK-STAT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

JAKs go nuclear: emerging role of nuclear JAK1 and JAK2 in gene expression and cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Nuclear Janus-activated kinase 2/nuclear factor 1-C2 suppresses tumorigenesis and epithelial-to-mesenchymal transition by repressing Forkhead box F1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Inflammatory mechanisms contributing to pancreatic cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Energy balance, host-related factors, and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Insulin resistance, serum adiponectin, and proinflammatory markers in young subjects with the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

STAT3 knockdown reduces pancreatic cancer cell invasiveness and matrix metalloproteinase-7 expression in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Combined blockade of Src kinase and epidermal growth factor receptor with gemcitabine overcomes STAT3-mediated resistance of inhibition of pancreatic tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Redefining the R1 resection in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Targeting the hypoxia-inducible factor (HIF) pathway in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6/signal-transducer and activator of transcription 3/hypoxia-inducible factor-1alpha autocrine loop, and reduces or

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Taming the dragon: genomic biomarkers to individualize the treatment of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2168-7

Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer

21 January 2018

1 reference

12 December 2020

Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Progression of Pancreatic Intraepithelial Neoplasia and Development of Pancreatic Cancer

1 reference

12 December 2020

Modulation of signal transducer and activator of transcription 3 activities by p53 tumor suppressor in breast cancer cells

1 reference

12 December 2020

Chronic Pancreatitis Is Essential for Induction of Pancreatic Ductal Adenocarcinoma by K-Ras Oncogenes in Adult Mice

1 reference

12 December 2020

Clinical Significance of Interleukin-6 (Il-6) Gene Polymorphism and Il-6 Serum Level in Pancreatic Adenocarcinoma and Chronic Pancreatitis

1 reference

12 December 2020

Expression of nuclear Notch3 in pancreatic adenocarcinomas is associated with adverse clinical features, and correlates with the expression of STAT3 and phosphorylated Akt

1 reference

12 December 2020

Toxicogenomic analysis of mainstream tobacco smoke-exposed mice reveals repression of plasminogen activator inhibitor-1 gene in heart

1 reference

12 December 2020

A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study

1 reference

12 December 2020

Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma

1 reference

12 December 2020

Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis

1 reference

12 December 2020

Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors

1 reference

12 December 2020

10.1007/S11605-013-2168-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23435739%20AND%20SRC:MED&resulttype=core&format=json

release_oxfjejzt5zhgrfosivxgj2d65i

24 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/oxfjejzt5zhgrfosivxgj2d65i

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23435739%20AND%20SRC:MED&resulttype=core&format=json